Metformin is Associated with Reduced COVID-19 Severity in Patients with Prediabetes

Mostrar otras versiones (1)

BACKGROUND: With the continuing COVID-19 pandemic, identifying medications that improve COVID-19 outcomes is crucial. Studies suggest that use of metformin, an oral antihyperglycemic, is associated with reduced COVID-19 severity in individuals with diabetes compared to other antihyperglycemic medica...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Lauren E., Casiraghi, Elena, Laraway, Bryan, Coleman, Ben, Blau, Hannah, Zaman, Adnin, Harris, Nomi, Wilkins, Kenneth, Gargano, Michael, Valentini, Giorgio, Sahner, David, Haendel, Melissa, Robinson, Peter N., Bramante, Carolyn, Reese, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460973/
https://www.ncbi.nlm.nih.gov/pubmed/36093353
http://dx.doi.org/10.1101/2022.08.29.22279355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460973/
https://www.ncbi.nlm.nih.gov/pubmed/36093353
http://dx.doi.org/10.1101/2022.08.29.22279355

Ejemplares similares